4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-24-000705
Chief Executive Officer bought 166,666 shares at $0.30 ($50,000)
From the SEC's structured data for this filing
Trades in this filing
Climaco John M · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-01 | Purchase : show line 1 in the form | +166,666 | $0.30 | $50,000 | 215,676 | D |
| Open-market purchases · 166,666 sh · avg $0.30 · $50,000 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-01 | Grant or award : show line 2 in the form Series A Warrant to purchase common stock | +166,666 | 226,867 | D |
| 2024-02-01 | Grant or award : show line 3 in the form Series B Warrant to purchase common stock | +166,666 | 393,533 | D |
Loading xslF345X05/ownership.xml…